From 2023 to 2026, analysts expect Robinhood's revenue to grow at a compound annual growth rate (CAGR) of 22%. On the bottom ...

There are plenty to choose from, and they're all soaring in price. That doesn't necessarily mean you should buy the stocks, though.

What's going on with CRISPR Therapeutics ( CRSP 0.83%)? The company's shares have been southbound for the better part of ...